Latest News and Press Releases
Want to stay updated on the latest news?
-
Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies EDEN PRAIRIE, Minn., May 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies...
-
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Cutanogen Corporation, an orphan clinical-stage regenerative medicine wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....
-
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...